Dashboard
Manage Tickers

DTILPRECISION BIOSCIENCES INC

Nasdaq precisionbiosciences.com


$ 10.42 $ -0.51 (-4.67 %)    

Friday, 10-May-2024 14:49:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.14 $ -0.73 (-0.16 %)
DIA $ 395.30 $ 0.04 (0.01 %)
SPY $ 520.95 $ -0.57 (-0.11 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 219.02 $ -0.76 (-0.35 %)
$ 10.93
$ 10.85
$ 10.40 x 200
$ 10.53 x 200
$ 10.24 - $ 10.85
$ 8.25 - $ 27.02
17,125
na
41.99M
$ 1.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-27-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-15-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-18-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-10-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 04-29-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

precision-biosciences-announces-common-stock-purchase-by-members-of-management-including-ceo--for-300000-in-private-placement
Precision BioSciences Announces Common Sto...
05/08/2024 12:18:51

precision-biosciences-announces-receipt-of-fda-fast-track-designation-for-ecur-506-iecures-program-for-the-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency
Precision BioSciences Announces Receipt Of...
05/07/2024 12:37:53

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

precision-biosciences-disclosed-late-breaking-poster-presentation-at-the-european-association-for-study-of-the-liver-congress-2024
Precision Biosciences Disclosed Late-break...
05/01/2024 11:27:47

guggenheim-initiates-coverage-on-precision-biosciences-with-buy-rating-announces-price-target-of-19
Guggenheim Initiates Coverage On Precision...
04/30/2024 11:41:44

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and anno...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
04/17/2024 17:26:55

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 12:08:12

precision-biosciences-announces-return-of-programs-and-conclusion-of-collaboration-with-prevail-therapeutics
Precision BioSciences Announces Return Of ...
04/16/2024 20:17:19

- Productive collaboration advanced three programs and demonstrated proof of concept of ARCUS for gene excision and gene insert...

iecure-announces-fda-clearance-of-ind-application-for-ecur-506-to-initiate-otc-hope-trial-for-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency-in-the-us-note-iecure-has-licensed-the-arcus-nuclease-for-ecur-506-from-precision-biosciences
iECURE Announces FDA Clearance Of IND Appl...
04/04/2024 15:02:53

Clinical trial sites in the United States, United Kingdom, and Australia will evaluate ECUR-506, an investigational gene editin...

hc-wainwright--co-maintains-buy-on-precision-biosciences-adjusts-price-target-to-60
HC Wainwright & Co. Maintains Buy on Preci...
03/28/2024 14:56:08

HC Wainwright & Co. analyst Patrick Trucchio maintains Precision BioSciences (NASDAQ:DTIL) with a Buy, adjusts target to...

precision-biosciences-2023-cash-and-cash-equivalents-of-1167m-cash-received-from-tg-therapeutics-caribou-of-50m-and-40m-capital-raise-is-expected-to-provide-cash-runway-into-2h-of-2026
Precision Biosciences' 2023 Cash And Cash ...
03/27/2024 10:58:57

precision-biosciences-q4-gaap-eps-406-may-not-be-comparable-to-205-estimate-sales-704m-miss-1248m-estimate
Precision BioSciences Q4 GAAP EPS $(4.06) ...
03/27/2024 10:48:11

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(4.06) per share which missed the analyst consensus estimate ...

earnings-scheduled-for-march-27-2024
Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

earnings-preview-precision-biosciences
Earnings Preview: Precision BioSciences
03/26/2024 17:00:59

precision-biosciences-announces-mhra-approval-for-partner-iecure-to-expand-phase-12-clinical-trial-of-arcus-gene-editing-program-in-otc-deficiency
Precision BioSciences Announces MHRA Appro...
03/06/2024 13:45:33

why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Zscaler Shares Are Trading Lower By 10...
03/01/2024 18:19:25

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/01/2024 17:34:56

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/01/2024 13:09:49

precision-biosciences-discloses-40m-offering-of-common-stock-and-warrants-warrants-have-an-exercise-price-of-2000-per-share-and-are-exercisable-immediately
Precision BioSciences Discloses $40M Offer...
03/01/2024 11:40:48

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/29/2024 21:31:36

precision-biosciences-announces-proposed-public-offering-of-common-stock-and-warrants-terms-not-disclosed
Precision BioSciences Announces Proposed P...
02/29/2024 21:04:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION